Journal List > Korean J Nutr > v.45(1) > 1043956

Kim and Kim: The Effect of Food Restriction on Appetite Regulating Hormones and Adiponectin Activity

Abstract

We investigated the effects of short-term food restriction and repeated fasting and refeeding on appetite regulating hormones and adiponectin activity in rats. To investigate the acute and chronic effects of food restriction in vivo, Sprague-Dawley rats were divided into a control group (CON), a 1 day fasting group, a 2 days fasting gruop, a 3 days fasting gruop, a fasting and refeeding for 1 week gruoup and a fasting and refeeding for 2 weeks group. Blood glucose, triglyceride and total cholesterol decreased in all fasting groups compared to those in the CON group. Free fatty acid of all fasting groups was higher than those in the CON, and were lowest in the three cycle fasting and refeeding group. Blood insulin following short-term food restriction was lower than that in the CON. blood ghrelin increased significantly (p < 0.01) following the short-term food restriction, However, blood ghrelin in the repeated fasting and refeeding groups decreased significantly decreased (p < 0.01) compared to that in the CON and short-term food restriction group. In contrast, blood leptin decreased significantly (p < 0.01) in the short term food restriction group and the three cycle of fasting and refeeding group but increased in the six cycle of fasting and refeeding group. No significant differences in adiponectin contents were observed in the short-term food restriction group. But, adiponectin increased significantly (p < 0.01) following the fasting and refeeding cycles. Blood adiponectin and blood leptin levels were showed positively correlated (r2 = 0.469) when all samples were analysed together.

Figures and Tables

Fig. 1
Correlation of the adiponectin and leptin.
kjn-45-5-g001
Fig. 2
Correlation of the adiponectin and the ghrelin.
kjn-45-5-g002
Table 1
Change of plasma concentration in the experimental groups
kjn-45-5-i001

Values are mean ± S.D.

a) p < 0.05 vs. CON b) p < 0.05 vs. F1D c) p < 0.05 vs. F2D d) p < 0.05 vs. F3D e) p < 0.05 vs. FR1W

CON: control, F1D: fasting for 1 day, F2D: fasting for 2 days, F3D: fasting for 2 days, FR1W: fasting and re-feeding for 1 week, FR2W: fasting and re-feeding for 2 weeks

Table 2
Change of appetite control hormone concentration in the experimental groups
kjn-45-5-i002

Values are mean ± S.D.

a) p < 0.05 vs. CON b) p < 0.05 vs. F1D c) p < 0.05 vs. F2D d) p < 0.05 vs. F3D e) p < 0.05 vs. FR1W

References

1. Ernsberger P, Koletsky RJ, Baskin JS, Collins LA. Consequences of weight cycling in obese spontaneously hypertensive rats. Am J Physiol. 1996. 270(4 Pt 2):R864–R872.
crossref
2. Jen KL, Lu H, Savona L, Watkins A, Shaw M. Long-term weight cycling reduces body weight and fat free mass, but not fat mass in female Wistar rats. Int J Obes Relat Metab Disord. 1995. 19(10):699–708.
3. Stein LJ, Stellar E, West DB, Greenwood MR, Foster GD, Feurer I, Brown J, Mullen JL, Brownell KD. Early-onset repeated dieting reduces food intake and body weight but not adiposity in dietary-obese female rats. Physiol Behav. 1992. 51(1):1–6.
crossref
4. Graham B, Chang S, Lin D, Yakubu F, Hill JO. Effect of weight cycling on susceptibility to dietary obesity. Am J Physiol. 1990. 259(6 Pt 2):R1096–R1102.
crossref
5. Wang H, Zhang H, Jia Y, Zhang Z, Craig R, Wang X, Elbein SC. Adiponectin receptor 1 gene (ADIPOR1) as a candidate for type 2 diabetes and insulin resistance. Diabetes. 2004. 53(8):2132–2136.
crossref
6. Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000. 407(6806):908–913.
crossref
7. Hellsten Y, Nielsen JJ, Lykkesfeldt J, Bruhn M, Silveira L, Pilegaard H, Bangsbo J. Antioxidant supplementation enhances the exercise-induced increase in mitochondrial uncoupling protein 3 and endothelial nitric oxide synthase mRNA content in human skeletal muscle. Free Radic Biol Med. 2007. 43(3):353–361.
crossref
8. Seki Y, Berggren JR, Houmard JA, Charron MJ. Glucose transporter expression in skeletal muscle of endurance-trained individuals. Med Sci Sports Exerc. 2006. 38(6):1088–1092.
crossref
9. Yang WS, Lee WJ, Funahashi T, Tanaka S, Matsuzawa Y, Chao CL, Chen CL, Tai TY, Chuang LM. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001. 86(8):3815–3819.
crossref
10. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999. 257(1):79–83.
crossref
11. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2002. 290(3):1084–1089.
crossref
12. Azuma K, Katsukawa F, Oguchi S, Murata M, Yamazaki H, Shimada A, Saruta T. Correlation between serum resistin level and adiposity in obese individuals. Obes Res. 2003. 11(8):997–1001.
crossref
13. Benson JD, Bensadoun A. Response of adipose tissue lipoprotein lipase to fasting in the chicken and the rat--a species difference. J Nutr. 1977. 107(6):990–997.
crossref
14. Bergö M, Wu G, Ruge T, Olivecrona T. Down-regulation of adipose tissue lipoprotein lipase during fasting requires that a gene, separate from the lipase gene, is switched on. J Biol Chem. 2002. 277(14):11927–11932.
crossref
15. Lee JJ, Smith PJ, Fried SK. Mechanisms of decreased lipoprotein lipase activity in adipocytes of starved rats depend on duration of starvation. J Nutr. 1998. 128(6):940–946.
crossref
16. Park SC, Park YH, Park SY, Kim JY, Park YK, Lee TH, Won KC, Kim YW. The effect of leptin level fluctuations by a repeated fasting/refeeding on the leptin sensitivity in OLETF rats. J Korean Endocr Soc. 2008. 23(5):310–318.
crossref
17. Bence KK, Delibegovic M, Xue B, Gorgun CZ, Hotamisligil GS, Neel BG, Kahn BB. Neuronal PTP1B regulates body weight, adiposity and leptin action. Nat Med. 2006. 12(8):917–924.
crossref
18. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995. 270(45):26746–26749.
crossref
19. Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000. 102(1):42–47.
crossref
20. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab. 2002. 87(12):5662–5667.
crossref
21. Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf). 2004. 61(3):332–338.
crossref
22. Numao S, Suzuki M, Matsuo T, Nomata Y, Nakata Y, Tanaka K. Effects of acute aerobic exercise on high-molecular-weight adiponectin. Med Sci Sports Exerc. 2008. 40(7):1271–1276.
crossref
23. O'Leary VB, Jorett AE, Marchetti CM, Gonzalez F, Phillips SA, Ciaraldi TP, Kirwan JP. Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. Am J Physiol Endocrinol Metab. 2007. 293(1):E421–E427.
24. Hara T, Fujiwara H, Nakao H, Mimura T, Yoshikawa T, Fujimoto S. Body composition is related to increase in plasma adiponectin levels rather than training in young obese men. Eur J Appl Physiol. 2005. 94(5-6):520–526.
crossref
25. Ryan AS, Berman DM, Nicklas BJ, Sinha M, Gingerich RL, Meneilly GS, Egan JM, Elahi D. Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity. Diabetes Care. 2003. 26(8):2383–2388.
crossref
26. Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001. 50(4):707–709.
crossref
27. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999. 402(6762):656–660.
crossref
28. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2000. 85(12):4908–4911.
crossref
29. Hataya Y, Akamizu T, Takaya K, Kanamoto N, Ariyasu H, Saijo M, Moriyama K, Shimatsu A, Kojima M, Kangawa K, Nakao K. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab. 2001. 86(9):4552–4555.
crossref
30. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding. Nature. 2001. 409(6817):194–198.
crossref
31. Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001. 50(2):227–232.
crossref
32. Kraemer RR, Castracane VD. Exercise and humoral mediators of peripheral energy balance: ghrelin and adiponectin. Exp Biol Med (Maywood). 2007. 232(2):184–194.
33. Zhang Y, Matheny M, Zolotukhin S, Tumer N, Scarpace PJ. Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3-adrenergic agonists, retinoic acid, leptin and fasting. Biochim Biophys Acta. 2002. 1584(2-3):115–122.
crossref
34. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001. 50(9):2094–2099.
crossref
35. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. Depot-and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes. 1997. 46(3):342–347.
crossref
36. Rosenbaum M, Pietrobelli A, Vasselli JR, Heymsfield SB, Leibel RL. Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution. Int J Obes Relat Metab Disord. 2001. 25(9):1365–1371.
crossref
TOOLS
Similar articles